Home Nucleus Biotechnology RoMEA Next Generation Sequencing (NGS) Market to 2032

RoMEA Next Generation Sequencing (NGS) Market to 2032

Overview

The RoMEA Next Generation Sequencing (NGS) Market is expected to reach a 340.59 USD Billion by 2032 and is projected to grow at a CAGR of 13.91% from 2025 to 2032.

Revenue, 2024 (USD Billion)
155.73
Forecast, 2032 (USD Billion)
340.59
CAGR, 2024 - 2032
13.91%
Report Coverage
RoMEA

RoMEA Next Generation Sequencing (NGS) Market 2018-2032 USD Billion

RoMEA Next Generation Sequencing (NGS) Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 155.73 USD Billion
  • Projected Market Size (2032): 340.59 USD Billion
  • CAGR (2025-2032): 13.91%

Key Findings of RoMEA Next Generation Sequencing (NGS) Market

  • The RoMEA Next Generation Sequencing (NGS) Market was valued at 155.73 USD Billion in 2024.
  • The RoMEA Next Generation Sequencing (NGS) Market is likely to grow at a CAGR of 13.91% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Pharmaceuticals Microbiology in Application Segment accounted for the largest share of the market with a revenue of 161.97 USD Billion
  • The fastest growing segment Services in Product & Service Segment grew Fastest with a CAGR of 14.96% during the forecast period from 2024 to 2032.

RoMEA Next Generation Sequencing (NGS) Market Scope

RoMEA Next Generation Sequencing (NGS) Market Segmentation & Scope
Distribution Channel
  • Others
  • Retail Sales
  • Direct Tender
Product & Service
  • Instruments
  • Services
  • Consumables
Application
  • Others
  • Food Pathogen Screening
  • Agricultural & Animal Research
  • Diagnostics
  • Precision Medicine
  • Drug & Biomarker Discovery
  • Pharmaceuticals Microbiology
End User
  • Others
  • Contract Research Organizations (CROS)
  • Clinical Laboratories
  • Hospitals & Clinics
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
Technology
  • Others
  • Sequencing By Ligation (SBL)
  • Sequencing By Synthesis (SBS)

RoMEA Next Generation Sequencing (NGS) Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Billion
Market Value in 2024 155.73 USD Billion
Market Value in 2032 340.59 USD Billion
CAGR (2025-2032) 13.91%
Historic Data 2016-2023
Market Segments Covered Distribution Channel,Product & Service,Application,End User,Technology

Regional Insights:

  • Leading Market (2024-2032): RoMEA, leading in terms of revenue 155.73 USD Billion in 2024
    • Key Country: RoMEA, leading in terms of revenue with value of 155.73 USD Billion in 2024.

Segments and Scope

  • RoMEA Next Generation Sequencing (NGS) Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in RoMEA Next Generation Sequencing (NGS) Market to 2032 with a revenue of 114.86 USD Billion in the year 2024.
    • Direct Tender is the Fastest growing segment in RoMEA Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 14.00 % in forecast period 2025-2032.
  • RoMEA Next Generation Sequencing (NGS) Market to 2032, By Product & Service
    • Consumables is the largest segment in RoMEA Next Generation Sequencing (NGS) Market to 2032 with a revenue of 104.26 USD Billion in the year 2024.
    • Services is the Fastest growing segment in RoMEA Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 13.68 % in forecast period 2025-2032.
  • RoMEA Next Generation Sequencing (NGS) Market to 2032, By Application
    • Pharmaceuticals Microbiology is the largest segment in RoMEA Next Generation Sequencing (NGS) Market to 2032 with a revenue of 161.97 USD Billion in the year 2024.
    • Pharmaceuticals Microbiology is the Fastest growing segment in RoMEA Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 14.35 % in forecast period 2025-2032.
  • RoMEA Next Generation Sequencing (NGS) Market to 2032, By End User
    • Pharmaceutical & Biotechnology Companies is the largest segment in RoMEA Next Generation Sequencing (NGS) Market to 2032 with a revenue of 92.91 USD Billion in the year 2024.
    • Pharmaceutical & Biotechnology Companies is the Fastest growing segment in RoMEA Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 14.21 % in forecast period 2025-2032.
  • RoMEA Next Generation Sequencing (NGS) Market to 2032, By Technology
    • Sequencing By Synthesis (SBS) is the largest segment in RoMEA Next Generation Sequencing (NGS) Market to 2032 with a revenue of 115.25 USD Billion in the year 2024.
    • Sequencing By Synthesis (SBS) is the Fastest growing segment in RoMEA Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 13.98 % in forecast period 2025-2032.

RoMEA Next Generation Sequencing (NGS) Market Company Share Analysis

 
Company Name Company Share Analysis
Merck KGaA
Thermo Fisher Scientific Inc.
QIAGEN
Charles River Laboratories
RoMEA Next Generation Sequencing (NGS) Market Company Share Analysis

RoMEA Next Generation Sequencing (NGS) Market Geographical Sales Distribution, 2018-2032 USD Billion

RoMEA Next Generation Sequencing (NGS) Market Geographical Sales Distribution, 2018-2032 USD Billion

RoMEA Next Generation Sequencing (NGS) Market Company Profiling

RoMEA Next Generation Sequencing (NGS) Market Company Profiling

Industry Related Reports

South America Cell And Gene Therapy Thawing Equipment Market
Middle East & Africa Cell And Gene Therapy Thawing Equipment Market
North America Cell And Gene Therapy Thawing Equipment Market
Europe Cell And Gene Therapy Thawing Equipment Market
Asia-Pacific Cell And Gene Therapy Thawing Equipment Market
Argentina Cell And Gene Therapy Thawing Equipment Market
Australia Cell And Gene Therapy Thawing Equipment Market
Belgium Cell And Gene Therapy Thawing Equipment Market
Brazil Cell And Gene Therapy Thawing Equipment Market
Canada Cell And Gene Therapy Thawing Equipment Market
Frequently Asked Questions
The RoMEA Next Generation Sequencing (NGS) Market is segmented based on Segmentation Distribution Channel,Product & Service,Application,End User,Technology.
RoMEA Next Generation Sequencing (NGS) Market was valued at USD 155.73(Revenue in USD Billion) in 2020.
RoMEA Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 13.91% during the forecast period of 2024 to 2032.
The Pharmaceuticals Microbiology segment is expected to dominate the RoMEA Next Generation Sequencing (NGS) Market, holding a largest market share of 161.97 USD Billion in 2024

Coming Soon....

RoMEA Next Generation Sequencing (NGS) Market Scope

RoMEA Next Generation Sequencing (NGS) Market Segmentation & Scope
Distribution Channel
  • Others
  • Retail Sales
  • Direct Tender
Product & Service
  • Instruments
  • Services
  • Consumables
Application
  • Others
  • Food Pathogen Screening
  • Agricultural & Animal Research
  • Diagnostics
  • Precision Medicine
  • Drug & Biomarker Discovery
  • Pharmaceuticals Microbiology
End User
  • Others
  • Contract Research Organizations (CROS)
  • Clinical Laboratories
  • Hospitals & Clinics
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
Technology
  • Others
  • Sequencing By Ligation (SBL)
  • Sequencing By Synthesis (SBS)
Frequently Asked Questions
The RoMEA Next Generation Sequencing (NGS) Market is segmented based on Segmentation Distribution Channel,Product & Service,Application,End User,Technology.
RoMEA Next Generation Sequencing (NGS) Market was valued at USD 155.73(Revenue in USD Billion) in 2020.
RoMEA Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 13.91% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Next Generation Sequencing (NGS) Market for final year is USD 340.59 (USD Billion).

RoMEA Next Generation Sequencing (NGS) Market Company Profiling

RoMEA Next Generation Sequencing (NGS) Market Company Profiling
Frequently Asked Questions
The RoMEA Next Generation Sequencing (NGS) Market is segmented based on Segmentation Distribution Channel,Product & Service,Application,End User,Technology.
RoMEA Next Generation Sequencing (NGS) Market was valued at USD 155.73(Revenue in USD Billion) in 2020.
RoMEA Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 13.91% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Next Generation Sequencing (NGS) Market for final year is USD 340.59 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.